A Comprehensive Monitoring Study on Electrocardiographic Assessments and Cardiac Events After Fingolimod First Dose—Possible Predictors of Cardiac Outcomes

Background: First dose observation for cardiac effects is required for fingolimod. Previous results in patients with relapsing remitting multiple sclerosis (RRMS) suggest that transient bradycardia and conduction abnormalities during the observation phase are rare, benign and reversible. Prior analy...

Descripció completa

Dades bibliogràfiques

Autors principals:	Volker Limmroth, Tjalf Ziemssen, Ingo Kleiter, Bert Wagner, Stephan Schmidt, Christoph Lassek, Monika Baier-Ebert, Guillaume Wendt, Ralf Dechend, Wilhelm Haverkamp
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2020-08-01
Col·lecció:	Frontiers in Neurology
Matèries:	fingolimod first dose electrocardiogram cardiac effects bradycardia atrioventricular conduction
Accés en línia:	https://www.frontiersin.org/article/10.3389/fneur.2020.00818/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!